Small island developing States (SIDS) vs Sri Lanka: Proportion of the target population who received
Small island developing States (SIDS)
63.0%
in 2024
Sri Lanka
98.0%
in 2024
Small island developing States (SIDS) rank
30th
Sri Lanka rank
17th
Proportion of the target population who received over time
- Small island developing States (SIDS)
- Sri Lanka
How they compare
Sri Lanka currently reports 98.0% against 63.0% in Small island developing States (SIDS), a difference of 35.0%.
That makes Sri Lanka's figure about 1.6 times Small island developing States (SIDS)'s.
Across all 24 years both countries report, Sri Lanka has been ahead every year.
Small island developing States (SIDS) ranks 30th and Sri Lanka ranks 17th of 37 groups.
Sri Lanka has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Small island developing States (SIDS) | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.2% | 90.8% | 69.6% | Sri Lanka |
| 2010s | 31.6% | 99.0% | 67.4% | Sri Lanka |
| 2020s | 56.8% | 97.6% | 40.8% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Small island developing States (SIDS) or Sri Lanka?
- Sri Lanka, at 98.0% against 63.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received between Small island developing States (SIDS) and Sri Lanka?
- 35.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Small island developing States (SIDS) and Sri Lanka?
- 24 years are reported by both, from 2001 to 2024.
- How do Small island developing States (SIDS) and Sri Lanka rank globally for proportion of the target population who received?
- Small island developing States (SIDS) ranks 30th and Sri Lanka ranks 17th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.